Pharmakonzern · Deutschland
Fresenius
Ein Konzern aus 62 Unternehmen: 1.378 Arzneimittel, verteilt auf 12 Länder.
Konzernstruktur
62 Unternehmen, verteilt auf 28 Länder
Wird geladen …
Pharmakonzern · Deutschland
Ein Konzern aus 62 Unternehmen: 1.378 Arzneimittel, verteilt auf 12 Länder.
62 Unternehmen, verteilt auf 28 Länder
Ein kostenloses Konto für die Prognia-Apps: Ward zum Lernen, Osler für klinische Antworten mit ihren Quellen und das Netzwerk, um deine Kolleginnen und Kollegen zu finden.
Prognia stellt Konzerne aus den Namen zusammen, die Behörden veröffentlichen, und aus Verknüpfungen zwischen Unternehmen; sie sind keine offizielle Konzernstruktur.
Alle Arzneimittel aller Unternehmen im Konzern, aktuelle zuerst.
1–25 von 1.378
| Arzneimittel | Wirkstoff | Land | Status | Zulassung |
|---|---|---|---|---|
| 0.9% SODIUM CHLORIDE INJECTION900 mg / 100 ml · Solution | Sodium chloride | Kanada | Im Handel | 2013 |
| 2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION20 mg / ml · Solution | Calcium gluconate | Kanada | Im Handel | 2025 |
| 5% DEXTROSE INJECTION50 mg / ml · Solution | Dextrose | Kanada | Im Handel | 2014 |
| ACETAMINOPHEN1gm/100ml (10mg/ml) | 500mg/50ml (10mg/ml) | 650mg/65ml (10mg/ml) · Solution | Paracetamol | Vereinigte Staaten | Im Handel | 2015 |
| ACETATO SODICO 1M FRESENIUS KABI CONCENTRADO PARA SOLUCION PARA PERFUSION1361 mg · Solución inyectable | Acetato sodio | Spanien | Im Handel | 2001 |
| ácido zoledrônico | Zoledronic acid | Brasilien | Zugelassen | 2019 |
| ACIDO ZOLEDRONICO KABI 4MG/5ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG0,80 mg · Concentrado para solución para perfusión | Zoledronic acid | Spanien | Im Handel | 2013 |
| ACYCLOVIR SODIUM INJECTION50 mg / ml · Solution | Aciclovir | Kanada | Im Handel | 1998 |
| ADDAVEN | Cloreto zinco, Cloreto férrico, Fluoreto, Cloreto cúprico, Dicloreto manganês, Selenium, Iodeto, Cloreto crômico, Molybdate | Brasilien | Zugelassen | 2020 |
| ADDAVEN CONCENTRATE FOR SOLUTION FOR INFUSION5.33 mcg/ml + 102.3 mcg/ml + 540 mcg/ml + 19.79 mcg/ml + 16.6 mcg/ml + 210 mcg/ml + 4.85 mcg/ml + 17.29 mcg/ml + 1050 mcg/ml · Infusion, solution concentrate | Chromic, Copper, Ferric citrate, Manganese, Potassium iodide, Fluoride, Molybdate, Selenium, Zinc | Singapur | Zugelassen | 2017 |
| ADDNUTRIV10 mcg / 10 ml + 380 mcg / 10 ml + 950 mcg / 10 ml + 130 mcg / 10 ml + 1100 mcg / 10 ml + 55 mcg / 10 ml + 19 mcg / 10 ml + 79 mcg / 10 ml + 5000 mcg / 10 ml · Solution | Chromium, Copper, Fluoride, Iodine, Iron, Manganese, Molybdenum, Selenium, Zinc | Kanada | Im Handel | 2020 |
| ADENOSINA KABI 3 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADA3 mg · Solución inyectable en jeringa precargada | Adenosine | Spanien | Im Handel | 2017 |
| Adenosine Fresenius Kabi 3 mg/ml, oplossing voor injectie in een voorgevulde spuitOplossing voor injectie | Adenosine | Niederlande | Zugelassen | 2015 |
| ADENOSINE INJECTION3 mg / ml · Solution | Adenosine | Kanada | Im Handel | 2017 |
| ADENOSINE INJECTION3 mg / ml · Solution | Adenosine | Kanada | Im Handel | 2017 |
| ADENOSINE INJECTION3 mg / ml · Solution | Adenosine | Kanada | Im Handel | 2007 |
| ADRIM – DOXORUBICIN HYDROCHLORIDE INJECTION USP 2MG/ML2 mg/ml · Injection, solution | Doxorubicin | Singapur | Zugelassen | 2021 |
| ÁGUA PARA INJEÇÃO | Água para injetáveis, Água para injeção | Brasilien | Zugelassen | 2004 |
| AGUA PARA PREPARACIONES INYECTABLES FRESENIUS KABI DISOLVENTE PARA USO PARENTERAL100 ml · Disolvente para uso parenteral | Agua para preparaciones inyectables | Spanien | Im Handel | 2001 |
| AGUA PARA PREPARACIONES INYECTABLES MEINSOL, DISOLVENTE PARA USO PARENTERAL100 ml · Disolvente para uso parenteral | Agua para preparaciones inyectables | Spanien | Im Handel | 1990 |
| Amikacin Kabi5mg/mL · rastvor za infuziju | Amikacin | Serbien | Zugelassen | 2024 |
| AMIKACINA KABI 5 MG/ML SOLUCION PARA PERFUSION6,68 mg · Solución para perfusión | Amikacin | Spanien | Zugelassen | 2020 |
| Aminomix 1 Novum, oplossing voor infusieOplossing voor infusie | Alanine, Arginine, Azijnzuur, Calciumchloride, Phenylalanine, Glucose, Glycero-1 dinatriumfosfaat, Glycine, Histidine, Acidum, Isoleucine, Kaliumhydroxide, Leucine, L-lysine, Magnesiumchloride, Methionine, Chloras, Proline, Serine, Taurine, Threonine, Tryptophan, Tyrosine, Valine, Zinkdichloride | Niederlande | Zugelassen | 2006 |
| Aminomix 2 Novum, oplossing voor infusieOplossing voor infusie | Alanine, Arginine, Azijnzuur, Calciumchloride, Phenylalanine, Glucose, Glycero-1 dinatriumfosfaat, Glycine, Histidine, Acidum, Isoleucine, Kaliumhydroxide, Leucine, L-lysine, Magnesiumchloride, Methionine, Cloreto, Proline, Serine, Taurine, Threonine, Tryptophan, Tyrosine, Valine, Zinkdichloride | Niederlande | Zugelassen | 2006 |
| AMINOSTERIL N-HEPA 8% | Isoleucine, L-isoleucine, L-leucine, Leucine, Lysine, L-lysine, L-methionine, Methionine, Acetylcysteine, Fenilalamina, L-phenylalanine, L-threonine, Threonine, L-tryptophan, Tryptophan, Levovalina, Arginine, L-arginine, Histidine, L-histidine, Glycine, Alanine, L-alanine, L-proline, Proline, L-serine, Serine | Brasilien | Zugelassen | 2008 |
Wo es Zulassungen hält oder Arzneimittel herstellt, und wie viele davon aktuell sind.
| Land | Arzneimittel | Aktuell | Früher | Unternehmen |
|---|---|---|---|---|
| Kanada | 223 | 167 | 56 | UnternehmenAlle Arzneimittel |
| Spanien | 212 | 161 | 51 | UnternehmenAlle Arzneimittel |
| Brasilien | 198 | 71 | 127 | UnternehmenAlle Arzneimittel |
| Niederlande | 188 | 188 | 0 | UnternehmenAlle Arzneimittel |
| Vereinigte Staaten | 138 | 136 | 2 | UnternehmenAlle Arzneimittel |
| Serbien | 115 | 106 | 9 | UnternehmenAlle Arzneimittel |
| Rumänien | 97 | 0 | 97 | UnternehmenAlle Arzneimittel |
| Kroatien | 69 | 69 | 0 | UnternehmenAlle Arzneimittel |
| Singapur | 67 | 67 | 0 | UnternehmenAlle Arzneimittel |
| Saudi-Arabien | 32 | 32 | 0 | UnternehmenAlle Arzneimittel |
| Taiwan | 26 | 7 | 19 | UnternehmenAlle Arzneimittel |
| Europäische Union (EMA) | 13 | 12 | 1 | UnternehmenAlle Arzneimittel |
Auch registriert in: Australien, Frankreich, Italien, Kolumbien, Malaysia, Schweden, Vereinigtes Königreich
Die ATC-Gruppen, zu denen die meisten seiner Arzneimittel gehören, größte zuerst.
Die Wirkstoffe in den meisten seiner Arzneimittel.
Wie die Register den Namen schreiben, normalisiert: ohne Rechtsform, Akzente und Großbuchstaben.
Von Prognia aus den unten genannten öffentlichen Arzneimittel- und Unternehmensregistern zusammengestellt. Logos werden nicht verwendet.
Prognia stellt Konzerne aus den Namen zusammen, die Behörden veröffentlichen, und aus Verknüpfungen zwischen Unternehmen; sie sind keine offizielle Konzernstruktur.
Source: European Medicines Agency (EPAR data).
Lizenz: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Lizenz: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Lizenz: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Lizenz: Licence Ouverte v1.0
ASIC,ASIC - Company Dataset,declared13October2026 extract,CC BY3.0 Australia,https://data.gov.au/data/dataset/asic-companies. Normalized and independently classified by Prognia;no endorsement.
Lizenz: Creative Commons Attribution 3.0 Australia
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Lizenz: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Lizenz: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Lizenz: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Lizenz: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Agência Nacional de Vigilância Sanitária (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Lizenz: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Lizenz: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Lizenz: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Lizenz: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes, dataset i7cb-raxc, rowsUpdatedAt 1792152574, acquired 2026-10-26; original values retained.
Lizenz: CC BY-SA 4.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Lizenz: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Lizenz: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Lizenz: BDPM exact Licence Ouverte v1.0 (October 2011)
BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.
Lizenz: BDPM exact Licence Ouverte v1.0 (October 2011)
INSEE (www.insee.fr), via DINUM API Recherche d’entreprises; include original record update date and retrieval date
Lizenz: Licence Ouverte / Open Licence
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Lizenz: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Lizenz: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods January–September 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Lizenz: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers
GLEIF; exact source URL and retrieval date; no endorsement.
Lizenz: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Lizenz: Otvorena dozvola RH
Contains Irish Public Sector Data licensed under Creative Commons Attribution 4.0 International (CC BY 4.0), Companies Registration Office; original dataset/API URL and company number, exact locator/source version and retrieval date; selected field normalization by Prognia. https://creativecommons.org/licenses/by/4.0/
Lizenz: Creative Commons Attribution
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Lizenz: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Lizenz: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Lizenz: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Lizenz: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Lizenz: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Lizenz: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Lizenz: Italian Open Data Licence
State Enterprise Centre of Registers / Valstybės įmonė Registrų centras; source dataset/resource URL, exact original code/UUID/revision, original CSV ordinal, retrieval time; CC BY 4.0 https://creativecommons.org/licenses/by/4.0/ ; selected field normalization by Prognia.
Lizenz: Creative Commons Attribution
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Lizenz: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Lizenz: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Contains data under the Norwegian licence for Open Government data (NLOD) distributed by Brønnøysundregistrene. https://data.norge.no/nlod/en/2.0; original API URLs, retrieval dates and locators. Selected and normalized by Prognia; fractional JSON numbers preserved as labelled exact decimal strings.
Lizenz: Norwegian Licence for Open Government Data
Ministerstwo Sprawiedliwości / Krajowy Rejestr Sądowy; original source URL, literal IDs and source locators, original creation/snapshot dates where present and acquisition time; selected fields normalized by Prognia; original statutory/MOJ reuse conditions
Lizenz: Statutory public-register API reuse with attribution conditions
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Lizenz: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Lizenz: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Lizenz: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Lizenz: Creative Commons Attribution 4.0 International (CC BY 4.0)
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Lizenz: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Lizenz: Singapore Open Data Licence
TFDA, dataset 9122, Government Open Data Licence 1.0; source update and retrieval dates
Lizenz: Taiwan Government Open Data Licence
U.S. Food and Drug Administration, Drugs@FDA API last updated 2026-10-23; full fixed 19-ID query acquired 2026-10-24T09:17:53.209180+00:00. Original facts retained; Prognia exact ID projection and later-reference resolution; no FDA endorsement.
Lizenz: openFDA factual NDC data, Creative Commons CC0 1.0 Universal / public domain, third-party and source-listing exceptions retained
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Lizenz: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Fehler melden oder Entfernung beantragenKorrekturen vom Unternehmen selbst sind willkommen.
Halten Sie die Arzneimittel von Fresenius auf Prognia korrekt, sehen Sie, wie Fachleute sie nutzen, und beantworten Sie ihre Fragen. Ein 20-minütiges Gespräch, auf Englisch.
Gespräch buchenBekannte Pharmakonzerne, jeweils mit allen Unternehmen.
Nach der Zahl ihrer Arzneimittel geordnet.